Neither the Parties nor the Patent Trial and Appeal Board (PTAB) have been resting in addressing the decision by the Federal Circuit that vacated ...

US biotech startup PerturbAI has emerged from stealth with what it describes as the largest in vivo CRISPR atlas to date, a dataset spanning 8 million brain-wide cells aimed at mapping gene function ...

CRISPR Therapeutics (NASDAQ:CRSP) has had a rough stretch lately. Shares have dropped 5% over the past week and are down 8% year-to-date, trading around $49.37 as of Tuesday morning. Piper Sandler, ...

A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using ...

A Dallas-based startup says it has produced three “de-extinct” dire wolf pups using gene-editing technology — and the dodo and woolly mammoth are next. But the gap between the company’s marketing and ...

"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

About three decades ago, an idea of scientists recreating dinosaurs first exploded into the public with the 1993 blockbuster ...

Windows 11 launched in 2021, bringing updates to your PC that focused on new Microsoft features and a lot of Copilot AI through continuous upgrades. While Windows 11 has been criticized as being a ...

CRISPR Therapeutics AG is commercially validated with CASGEVY but remains financially unproven and operates at a loss despite strong cash reserves. Incremental buying is attractive now for patient ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...

NASCAR is hoping to avoid delays that would prevent the entire race from being completed. Jared C. Tilton / Getty Images DAYTONA BEACH, Fla. — Due to the potential of inclement weather later in the ...